Alkermes plc (ALKS) CEO Richard Pops on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/13/20
Alkermes (ALKS) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 01/16/20
All You Need to Know About Alkermes (ALKS) Rating Upgrade to Strong BuyZacks Investment Research • 12/20/19
Alkermes (ALKS) Up 3% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 11/22/19
Biogen and Alkermes Announce FDA Approval of VUMERITY™ (diroximel fumarate) for Multiple SclerosisGlobeNewsWire • 10/30/19
Biogen's and Alkermes' Vumerity gets FDA approval for MS; Biogen's stock surgesMarket Watch • 10/30/19